Phibro Animal Health Corp. (PAHC)
37.94
-0.44
(-1.15%)
USD |
NASDAQ |
Oct 28, 16:00
37.94
0.00 (0.00%)
After-Hours: 16:37
Phibro Animal Health Enterprise Value : 2.264B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 2.264B |
| October 26, 2026 | 2.290B |
| October 23, 2026 | 2.281B |
| October 22, 2026 | 2.322B |
| October 21, 2026 | 2.299B |
| October 20, 2026 | 2.281B |
| October 19, 2026 | 2.303B |
| October 16, 2026 | 2.281B |
| October 15, 2026 | 2.247B |
| October 14, 2026 | 2.245B |
| October 13, 2026 | 2.200B |
| October 12, 2026 | 2.225B |
| October 09, 2026 | 2.260B |
| October 08, 2026 | 2.224B |
| October 07, 2026 | 2.237B |
| October 06, 2026 | 2.192B |
| October 05, 2026 | 2.215B |
| October 02, 2026 | 2.217B |
| October 01, 2026 | 2.162B |
| September 30, 2026 | 2.157B |
| September 29, 2026 | 2.145B |
| September 28, 2026 | 2.155B |
| September 25, 2026 | 2.104B |
| September 24, 2026 | 2.083B |
| September 23, 2026 | 2.090B |
| Date | Value |
|---|---|
| September 22, 2026 | 2.133B |
| September 21, 2026 | 2.114B |
| September 18, 2026 | 2.109B |
| September 17, 2026 | 2.104B |
| September 16, 2026 | 2.139B |
| September 15, 2026 | 2.128B |
| September 14, 2026 | 2.165B |
| September 11, 2026 | 2.152B |
| September 10, 2026 | 2.191B |
| September 09, 2026 | 2.200B |
| September 08, 2026 | 2.220B |
| September 04, 2026 | 2.258B |
| September 03, 2026 | 2.272B |
| September 02, 2026 | 2.326B |
| September 01, 2026 | 2.263B |
| August 31, 2026 | 2.238B |
| August 28, 2026 | 2.235B |
| August 27, 2026 | 2.181B |
| August 26, 2026 | 2.171B |
| August 25, 2026 | 2.164B |
| August 24, 2026 | 2.139B |
| August 21, 2026 | 2.180B |
| August 20, 2026 | 2.134B |
| August 19, 2026 | 2.144B |
| August 18, 2026 | 2.112B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.38B |
| Zoetis, Inc. | 39.96B |
| Corcept Therapeutics, Inc. | 9.154B |
| Abbott Laboratories | 206.06B |
| Merck & Co., Inc. | 396.88B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 21.71M |
| Revenue (Quarterly) | 396.75M |
| Total Expenses (Quarterly) | 375.04M |
| EPS Diluted (Quarterly) | 0.5295 |
| Gross Profit Margin (Quarterly) | 33.68% |
| Profit Margin (Quarterly) | 5.47% |
| Earnings Yield | 6.42% |
| Operating Earnings Yield | 12.92% |
| Normalized Earnings Yield | 7.087 |